Effect of U and 137Cs chronic contamination on dopamine and serotonin metabolism in the central nervous system of the rat

Canadian Journal of Physiology and Pharmacology

Volumn 82, Issue 2, 2004, Pages 161-166

  Houpert, P ^a   Lestaevel, P ^a   Amourette, C ^b   Dhieux, B ^a   Bussy, C ^a   Paquet, F ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b CENTRE DE RECHERCHES   (France)

Author keywords

Caesium; Dopamine; HPLC; Serotonin; Uranium

Indexed keywords

CESIUM 137; URANIUM; 3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 3-METHOXYTYRAMINE; 5 HYDROXYINDOLEACETIC ACID; CESIUM; DOPAMINE; DRUG DERIVATIVE; HOMOVANILLIC ACID; SEROTONIN; WATER;

ANIMAL TISSUE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; IRRADIATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RAT; SEROTONIN METABOLISM; STATISTICAL SIGNIFICANCE; THALAMUS; WATER CONTAMINATION; ANIMAL; ARTICLE; BRAIN; COMPARATIVE STUDY; DRINKING; KIDNEY; METABOLISM; RADIATION EXPOSURE; RADIOACTIVE CONTAMINATION; SPRAGUE DAWLEY RAT; WATER POLLUTANT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN; CESIUM RADIOISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DRINKING; FOOD CONTAMINATION, RADIOACTIVE; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; URANIUM; WATER; WATER POLLUTANTS, RADIOACTIVE;

EID: 2042477359     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y04-012     Document Type: Conference Paper

References (30)

1. Abou-Donia, M.B., Dechkovskaia, A.M., Goldstein, L.B., Shah, D.U., Bullman, S.L., and Khan, W.A 2002. Uranyl acetate-induced sensorimotor deficit and increased nitric oxide generation in the central nervous system in rats. Pharmacol. Biochem. Behav. 72: 881-90.
2. Aymard, N., Belkahla, F., Curet, O., and Boulu, R.G. 1983. Détermination des monoamines cérébrales et de leurs metabolites chez le rat par chromatographie liquide haute performance avec detection électrochimique. Act. Pharm. Bio. Clin. 2: 175-179.
3. Bandazhevsky, Y.I., and Lelevich, V.V. 1995. Clinical and experimental aspects of the effect of incorporated radionuclides upon the organism. Belorussian Engineering Academy - Gomel State Medical Institute, Gomel, Belarus.
4. Bassant, M.H., and Court, L. 1978. Effects of whole-body gamma irradiation on the activity of rabbit hippocampal neurons. Radiat. Res. 75: 593-606.
5. 137Cs et l'accident de Tchernobyl, projet international AIEA. In Actualités sur le césium. Jouve, Paris, pp. 10-16.
6. Foulon, O., Lalouette, F., Lambert, F., Martin, S., Fatôme, M., and Martin, C. 1999. Effect of neutron-gamma radiation on dopamine and serotonin metabolism in the rat brain: a regional analysis. J. Neurosci. Res. 55: 770-775.
7. Fuller, R.W. 1992. Basic advances in serotonin pharmacology. J. Clin. Psychiatry 53: 36-45.
8. Gilman, A.P., Villeneuve, D.C., Secours, V.E., Yagminas, A.P., Tracy, B.L., Quinn, J.M., Valli, V.E., Willes, R.J., and Moss, M.A. 1998. Uranyl nitrate: 28-day and 91-day toxicity studies in the Sprague-Dawley rat. Toxicol. Sci. 41: 117-128.
9. Goasguen, J., Lapresle, J., Ribot, C., and Rocquet, G. 1982. Chronic neurological syndrome resulting from intoxication with metallic uranium. Nouv. Presse Med. 11: 119-121.
10. Grahame-Smith, D.G., and Wang, H. 1992. Comparison of the actions of lithium, rubidium, and caesium on rat brain 5-HT function: pharmacological implications of ion channel function. Clin. Neuropharmacol. 15: 614A-615A.
11. Havenaar, J.M., Rumyantzeva, G.M., van den Brink, W., Poelijoe, N.W., van den Bout, J., van Engeland, H., and Koeter, M.W. 1997. Long-term mental health effects of the Chernobyl disaster: an epidemiologic survey in two former Soviet regions. Am. J. Psychiatry 154: 1605-1607.
12. Hodge, H.C., Stannard, J.N., and Hudge, J.B. 1973. Uranium, plutonium, transplutonic elements. Springer Verlag, New York.
13. Howland, J.W., Voegtlin, C., and Hodge, H.C. 1989. Studies on human exposures to uranium. McGraw-Hill Company, New York.
14. Hunt, W.A., Dalton, T.K., and Darden, J.H. 1979. Transient alterations in neurotransmitter activity in the caudate nucleus of rat brain after a high dose of ionizing radiation. Radiat. Res. 80: 556-562.
15. Ivanov, V.K., Maksioutov, M.A., Chekin, S.Y., Kruglova, Z.G., Petrov, A.V., and Tsyb, A.F. 2000. Radiation-epidemiological analysis of incidence of non-cancer diseases among the Chernobyl liquidators. Health Phys. 78: 495-501.
16. Lemercier, V., Millot, X., Ansoborlo, E., Ménétier, F., and Flury-Hérard, A. 2003. Study of uranium tranfer across the bloodbrain barrier. Radiat. Prot. Dosimetry, 105: 243-245.
17. McDiarmid, M.A., Keogh, J.P., Hooper, F.J., McPhaul, K., Squibb, K., Kane, R., DiPino, R., Kabat, M., Kaup, B., Anderson, L., Hoover, D., Brown, L., Hamilton, M., Jacobson-Kram, D., Burrows, B., and Walsh, M. 2000. Health effects of depleted uranium on exposed Gulf War veterans. Environ. Res. 82: 168-180.
18. McDiarmid, M.A., Squibb, K., Engelhardt, S., Oliver, M., Gucer, P., Wilson, P.D., Kane, R., Kabat, M., Kaup, B., Anderson, L., Hoover, D., Brown, L., and Jacobson-Kram, D. 2001. Surveillance of depleted uranium exposed Gulf War veterans: health effects observed in an enlarged "friendly fire" cohort. J. Occup. Environ. Med. 43: 991-1000.
19. Martin, C., Martin, S., Viret, R., Denis, J., Mirguet, F., Diserbo, M., Multon, E., and Lamproglou, I. 2001. Low dose of the gamma acute radiation syndrome (1.5 Gy) does not significantly alter either cognitive behavior or dopaminergic and serotoninergic metabolism. Cell. Mol. Biol. 47: 459-465.
20. Messiha, F.S. 1976. Distribution and retention of exogenously administered alkali metal ions in the mouse brain. Arch. Int. Pharmacodyn. Ther. 219: 87-96.
21. Messiha, F.S. 1978. Anti-depressant action of caesium chloride and its modification of chlorpromazine toxicity in mice. Br. J. Pharmacol. 64: 9-12.
22. Messiha, F.S. 1984. Lithium, rubidium and cesium: cerebral pharmacokinetics and alcohol interactions. Pharmacol. Biochem. Behav. 21: 87-92.
23. Messiha, F.S., and Krantz, J.C. Jr. 1973. Effect of cesium ion on cerebral activity of the mouse. Am. J. Pharm. Sci. Support Public Health 145: 17-21.
24. Pellmar, T.C., Fuciarelli, A.F., Ejnik, J.W., Hamilton, M., Hogan, J., Strocko, S., Emond, C., Mottaz, H.M., and Landauer, M.R. 1999a. Distribution of uranium in rats implanted with depleted uranium pellets. Toxicol. Sci. 49: 29-39.
25. Pellmar, T.C., Keyser, D.O., Emery, C., and Hogan, J.B. 1999b. Electrophysiological changes in hippocampal slices isolated from rats embedded with depleted uranium fragments. Neurotoxicology, 20: 785-792.
26. 238U series radionuclides as a source of increased radioactivity in groundwater originating from Finnish bedrock. In Future groundwater resources at risk. International Association of Hydrological Sciences, Wallingford, UK. pp. 71-84.
27. Spoor, N.L., and Hursh, J.B. 1973. Protection criteria. In Handbook of experimental pharmacology. Edited by H.C. Hodge, J.N. Stannard, and J.B. Hursh. Springer-Verlag, New York. pp. 241-270.
28. Wang, H., and Grahame-Smith, D.G. 1992. The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse - 2. Caesium. Neuropharmacology, 31: 421-424.
29. Willis, G.L. 1987. Amine accumulation in Parkinson's disease and other disorders. Neurosci. Biobehav. Rev. 11: 97-105.
30. Wolf, S.S., Hyde, T.M., and Weinberger, D.R. 1993. Neurobiology of schizophrenia. Curr. Opin. Neurol. Neurosurg. 6: 86-92.